ChemPacific is an API manufacturer based in United States. It holds 8 active US drug master files across a filed portfolio of 10 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 15 February 2024 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Baltimore, United States | 3003299802 |
| Molecule | Regulators | Docs |
|---|---|---|
| Bendamustine | US FDA | 1 |
| Busulfan | US FDA | 1 |
| Carmustine | US FDA | 1 |
| Dyclonine | US FDA | 1 |
| Melphalan | US FDA | 1 |
| Noradrenaline Bitartrate | SFDA (Saudi Arabia) | 1 |
| Norepinephrine | US FDA | 1 |
| Norepinephrine Bitartrate | SFDA (Saudi Arabia) | 1 |
| Pentostatin | US FDA | 1 |
| Procarbazine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
Choose your molecules and target markets. ChemPacific comes back tiered against every other supplier able to file there.
Start for free